ATOSSA THERAPEUTICS, INC. Investing Cash Flow
ATOSSA THERAPEUTICS, INC. (ATOS) reported Investing Cash Flow of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-07
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was $0.00.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was $0.00.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$7.00K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$7.00K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2025 was -$23.00K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2024 was -$19.00K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2023 was -$14.00K.
- ATOSSA THERAPEUTICS, INC. net cash provided by (used in) investing activities for fiscal 2022 was -$4.73M.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed | Net Cash Provided by (Used in) Investing Activities 41 month | Net Cash Provided by (Used in) Investing Activities 44 month | Net Cash Provided by (Used in) Investing Activities 47 month | Net Cash Provided by (Used in) Investing Activities 50 month | Net Cash Provided by (Used in) Investing Activities 53 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $0.00 10-Q · filed 2026-08-07 | -$7.00K derived: sum of 3 quarters · filed 2026-08-07 | -$14.00K derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-08 | -$7.00K derived: sum of 2 quarters · filed 2026-05-08 | -$14.00K derived: sum of 3 quarters · filed 2026-05-08 | -$14.00K derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2025-12-31 | -$7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$14.00K derived: sum of 2 quarters · filed 2026-03-25 | -$14.00K derived: sum of 3 quarters · filed 2026-08-07 | -$23.00K 10-K · filed 2026-03-25 | |||||||
| 2025-09-30 | -$7.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$7.00K derived: sum of 2 quarters · filed 2026-08-07 | -$16.00K 10-Q · filed 2025-11-12 | -$16.00K derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$9.00K 10-Q · filed 2026-08-07 | -$9.00K derived: sum of 3 quarters · filed 2026-08-07 | -$19.00K derived: sum of 4 quarters · filed 2026-08-07 | |||||||
| 2025-03-31 | -$9.00K 10-Q · filed 2026-05-08 | -$9.00K derived: sum of 2 quarters · filed 2026-05-08 | -$19.00K derived: sum of 3 quarters · filed 2026-05-08 | -$22.00K derived: sum of 4 quarters · filed 2026-05-08 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | -$10.00K derived: sum of 2 quarters · filed 2026-03-25 | -$13.00K derived: sum of 3 quarters · filed 2026-03-25 | -$19.00K 10-K · filed 2026-03-25 | |||||||
| 2024-09-30 | -$10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$13.00K derived: sum of 2 quarters · filed 2025-11-12 | -$19.00K 10-Q · filed 2025-11-12 | -$19.00K derived: sum of 4 quarters · filed 2025-11-12 | |||||||
| 2024-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$9.00K 10-Q · filed 2025-08-12 | -$9.00K derived: sum of 3 quarters · filed 2025-08-12 | -$10.00K derived: sum of 4 quarters · filed 2025-08-12 | |||||||
| 2024-03-31 | -$6.00K 10-Q · filed 2025-05-13 | -$6.00K derived: sum of 2 quarters · filed 2025-05-13 | -$7.00K derived: sum of 3 quarters · filed 2025-05-13 | -$20.00K derived: sum of 4 quarters · filed 2025-05-13 | |||||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-25 | -$1.00K derived: sum of 2 quarters · filed 2025-03-25 | -$14.00K derived: sum of 3 quarters · filed 2025-03-25 | -$14.00K 10-K · filed 2025-03-25 | |||||||
| 2023-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$14.00K derived: sum of 2 quarters · filed 2024-11-12 | -$14.00K 10-Q · filed 2024-11-12 | -$2.02M derived: sum of 4 quarters · filed 2024-11-12 | |||||||
| 2023-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | -$13.00K 10-Q · filed 2024-08-12 | -$2.02M derived: sum of 3 quarters · filed 2024-08-12 | -$4.73M derived: sum of 4 quarters · filed 2024-08-12 | |||||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-13 | -$2.01M derived: sum of 2 quarters · filed 2024-05-13 | -$4.71M derived: sum of 3 quarters · filed 2024-05-13 | -$4.71M derived: sum of 4 quarters · filed 2024-05-13 | |||||||
| 2022-12-31 | -$2.01M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | -$4.71M derived: sum of 2 quarters · filed 2024-04-01 | -$4.71M derived: sum of 3 quarters · filed 2024-04-01 | -$4.73M 10-K · filed 2024-04-01 | |||||||
| 2022-09-30 | -$2.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | -$2.71M derived: sum of 2 quarters · filed 2023-11-13 | -$2.72M 10-Q · filed 2023-11-13 | -$2.72M derived: sum of 4 quarters · filed 2023-11-13 | |||||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | -$13.00K 10-Q · filed 2023-08-14 | -$13.00K derived: sum of 3 quarters · filed 2023-08-14 | -$22.00K derived: sum of 4 quarters · filed 2023-08-14 | |||||||
| 2022-03-31 | -$13.00K 10-Q · filed 2023-05-15 | -$13.00K derived: sum of 2 quarters · filed 2023-05-15 | -$22.00K derived: sum of 3 quarters · filed 2023-05-15 | -$22.00K derived: sum of 4 quarters · filed 2023-05-15 | |||||||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-22 | -$9.00K derived: sum of 2 quarters · filed 2023-03-22 | -$9.00K derived: sum of 3 quarters · filed 2023-03-22 | -$9.00K 10-K · filed 2023-03-22 | |||||||
| 2021-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$9.00K derived: sum of 2 quarters · filed 2022-11-07 | -$9.00K 10-Q · filed 2022-11-07 | -$9.40K 10-Q · filed 2021-11-15 | -$8.63K derived: sum of 4 quarters · filed 2022-11-07 | ||||||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $367.00 derived: sum of 3 quarters · filed 2022-08-08 | -$2.39K derived: sum of 4 quarters · filed 2022-08-08 | |||||||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-09 | $367.00 derived: sum of 2 quarters · filed 2022-05-09 | -$2.39K derived: sum of 3 quarters · filed 2022-05-09 | ||||||||
| 2020-12-31 | $367.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$2.39K derived: sum of 2 quarters · filed 2022-02-28 | -$9.00K 10-K · filed 2022-02-28 | -$9.37K 10-K · filed 2021-03-31 | |||||||
| 2020-09-30 | -$2.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$9.37K 10-Q · filed 2021-11-15 | |||||||||
| 2020-06-30 | -$6.61K 10-Q · filed 2021-08-13 | ||||||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $0.00 derived: sum of 2 quarters · filed 2021-03-31 | -$7.63K 10-K · filed 2021-03-31 | ||||||||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$7.63K 10-Q · filed 2020-11-13 | |||||||||
| 2019-06-30 | -$7.63K 10-Q · filed 2020-08-13 | ||||||||||
| 2018-12-31 | -$56.46K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$59.41K derived: sum of 2 quarters · filed 2020-03-26 | -$59.84K derived: sum of 3 quarters · filed 2020-03-26 | -$110.91K 10-K · filed 2020-03-26 | |||||||
| 2018-09-30 | -$2.96K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | -$3.38K derived: sum of 2 quarters · filed 2019-11-13 | -$54.45K 10-Q · filed 2019-11-13 | ||||||||
| 2018-06-30 | -$423.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | -$51.49K 10-Q · filed 2019-08-13 | |||||||||
| 2018-03-31 | -$51.07K 10-Q · filed 2019-05-13 | ||||||||||
| 2016-12-31 | -$4.19K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | -$4.27K derived: sum of 2 quarters · filed 2018-03-08 | -$4.19K derived: sum of 3 quarters · filed 2018-03-08 | -$9.21K 10-K · filed 2018-03-08 | |||||||
| 2016-09-30 | -$82.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | -$3.00 derived: sum of 2 quarters · filed 2017-11-13 | -$5.02K 10-Q · filed 2017-11-13 | -$182.69K derived: sum of 4 quarters · filed 2017-11-13 | |||||||
| 2016-06-30 | $79.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$4.94K 10-Q · filed 2017-08-14 | -$182.61K derived: sum of 3 quarters · filed 2017-08-14 | -$211.69K derived: sum of 4 quarters · filed 2017-08-14 | |||||||
| 2016-03-31 | -$5.02K 10-Q · filed 2017-05-11 | -$182.69K derived: sum of 2 quarters · filed 2017-05-11 | -$211.77K derived: sum of 3 quarters · filed 2017-05-11 | -$227.40K derived: sum of 4 quarters · filed 2017-05-11 | |||||||
| 2015-12-31 | -$177.67K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2017-03-21 | -$206.75K derived: sum of 2 quarters · filed 2017-03-21 | -$222.38K derived: sum of 3 quarters · filed 2017-03-21 | -$288.42K 10-K/A · filed 2017-03-21 | |||||||
| 2015-09-30 | -$29.08K derived: 10-Q/A 9 month − 10-Q/A 6 month · filed 2017-03-21 | -$44.71K derived: sum of 2 quarters · filed 2017-03-21 | -$110.75K 10-Q/A · filed 2017-03-21 | ||||||||
| 2015-06-30 | -$15.63K derived: 10-Q/A 6 month − 10-Q/A 3 month · filed 2017-03-21 | -$81.67K 10-Q/A · filed 2017-03-21 | |||||||||
| 2015-03-31 | -$66.03K 10-Q/A · filed 2017-03-21 | ||||||||||
| 2014-12-31 | -$343.26K 10-K · filed 2016-03-30 | ||||||||||
| 2013-09-30 | -$310.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$392.17K derived: sum of 2 quarters · filed 2013-11-12 | -$400.67K 10-Q · filed 2013-11-12 | -$535.26K derived: sum of 4 quarters · filed 2013-11-12 | -$672.19K 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | -$81.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$89.87K 10-Q · filed 2013-08-14 | -$224.45K derived: sum of 3 quarters · filed 2013-08-14 | -$224.45K derived: sum of 4 quarters · filed 2013-11-12 | -$361.38K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | -$8.50K 10-Q · filed 2013-05-15 | -$143.08K derived: sum of 2 quarters · filed 2013-05-15 | -$143.08K derived: sum of 3 quarters · filed 2013-11-12 | -$143.08K derived: sum of 4 quarters · filed 2013-11-12 | -$280.01K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | -$134.58K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$134.58K derived: sum of 2 quarters · filed 2013-11-12 | -$134.58K derived: sum of 3 quarters · filed 2013-11-12 | -$134.58K 10-K · filed 2013-03-28 | -$271.51K 10-K · filed 2013-03-28 | ||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | $0.00 derived: sum of 2 quarters · filed 2013-11-12 | $0.00 10-Q · filed 2013-11-12 | -$51.66K derived: sum of 4 quarters · filed 2013-11-12 | -$136.93K 10-Q/A · filed 2013-01-22 | ||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $0.00 10-Q · filed 2013-08-14 | -$51.66K derived: sum of 3 quarters · filed 2013-08-14 | ||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | -$51.66K derived: sum of 2 quarters · filed 2013-05-15 | |||||||||
| 2011-12-31 | -$51.66K derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | -$136.93K 10-K · filed 2013-03-28 | |||||||||
| 2011-09-30 | -$85.28K 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |